Company Filing History:
Years Active: 2013-2021
Title: Innovations by Subramanian Natesan
Introduction
Subramanian Natesan is a notable inventor based in Tiruchirappalli, India. He has made significant contributions to the field of ophthalmic compositions, holding a total of four patents. His work primarily focuses on the development of pharmaceutical compositions that utilize calcineurin inhibitors and mTOR inhibitors for treating ocular diseases.
Latest Patents
Natesan's latest patents involve innovative ophthalmic compositions. These compositions comprise calcineurin inhibitors or mTOR inhibitors, aimed at treating various ocular diseases and conditions. The patents detail a pharmaceutical composition that includes a calcineurin inhibitor or an mTOR inhibitor, along with a first surfactant with an HLB index greater than about 10 and a second surfactant with an HLB index greater than about 13. The compositions are designed to form mixed micelles, enhancing their effectiveness in ocular treatments.
Career Highlights
Throughout his career, Subramanian Natesan has worked with prominent companies in the pharmaceutical industry. He has been associated with Lux Biosciences, Inc. and Aurinia Pharmaceuticals, Inc., where he contributed to the development of innovative treatments in ophthalmology. His expertise in formulating effective pharmaceutical compositions has been instrumental in advancing ocular therapies.
Collaborations
Natesan has collaborated with esteemed professionals in his field, including Ashim K Mitra and Poonam R Velagaleti. These collaborations have further enriched his research and development efforts, leading to significant advancements in ophthalmic compositions.
Conclusion
Subramanian Natesan's contributions to the field of ophthalmic compositions highlight his innovative spirit and dedication to improving ocular health. His patents and collaborations reflect a commitment to advancing pharmaceutical science, making a lasting impact in the industry.